New Drug Shows Promise for Resistant Thyroid Cancer
SATURDAY, May 31, 2014 (HealthDay News) -- A new oral drug
called lenvatinib looks promising as a treatment for a type of
thyroid cancer that resists standard radiation, according to a
later-stage clinical trial.
Pair of Pills Shows Promise for Recurrent Ovarian Cancer
SATURDAY, May 31, 2014 (HealthDay News) -- A combination of two
new pills may nearly double the length of survival for patients
with recurrent ovarian cancer, according to preliminary clinical
Experimental Drug May Extend Lung Cancer Survival, Study Suggests
SATURDAY, May 31, 2014 (HealthDay News) -- A new "targeted"
therapy might help extend the lives of patients with advanced lung
cancer who have a relapse after their initial treatment, a clinical